Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 100

Sort by

Sort Order Select

Journal Articles

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Renal Biomarker with Potential Clinical Applications in Monoclonal Gammopathy of Renal Significance (MGRS)

Eftathios Kastritis, Ioannis Papassotiriou, PhD, Maria Roussou, MD, Maria Gavriatopoulou, MD, Mantzou Aimilia, PhD, Erasmia Psimenou, MD, Smaragdi Marinaki, Charikleia Gakiopoulou, MD, Alexandra Margeli, PhD, Nikolaos Kanellias, MD, Magdalini Migkou, MD, Despina Fotiou, BMBS, MA, Ioannis Ntanasis-Stathopoulos, MD, Gerasimos-Petros Papassotiriou, PhD, Aristea-Maria Papanota, MD, Evangelos Terpos, MD PhD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 3126.

https://doi.org/10.1182/blood-2019-125305

Published: 2019

Journal Articles

Does Gene Therapy in Beta Thalassemia Normalize Novel Markers of Ineffective Erythropoiesis and Iron Homeostasis?

Alexis A. Thompson, MD MPH, Tomas Ganz, MD PhD, Mary Therese Forsyth, Elizabeta Nemeth, PhD, Sherif M. Badawy, MD

Blood (2019) 134 (Supplement_1): 816.

https://doi.org/10.1182/blood-2019-129658

Published: 2019

Journal Articles

Serum Neutrophil Gelatinase-Associated Lipocalin Independently Predicts for Renal Response in Myeloma Patients with Severe Renal Impairment

Meletios A. Dimopoulos, MD, Maria Roussou, MD, Eftathios Kastritis, Alexandra Margeli, PhD, Evangelos Eleutherakis-Papaiakovou, MD, Ioannis Ntanasis-Stathopoulos, MD, Nikolaos Kanellias, MD, Gerasimos-Petros Papassotiriou, PhD, Despina Fotiou, MD, Magdalini Migkou, MD, Maria Gavriatopoulou, MD, Erasmia Psimenou, MD, Ioannis Papassotiriou, PhD, Evangelos Terpos, MD PhD

Blood (2019) 134 (Supplement_1): 1877.

https://doi.org/10.1182/blood-2019-123912

Published: 2019

Journal Articles

Evaluation of in Vitro Macrophage Characterization in Gaucher Type 1 (GD1) Patients

Paola Delbini, PhD, Viola Ghiandai, Maria Domenica Cappellini, MD, Lorena Duca, Isabella Nava, Elena Cassinerio, MD, Irene Motta, MD

Blood (2019) 134 (Supplement_1): 3592.

https://doi.org/10.1182/blood-2019-130032

Published: 2019

Journal Articles

Non Invasive Evaluation of Bone Marrow Activity in Patients with Sickle Cell Disease: Correlation with Disease Features, Genotype, Markers of Erythropoiesis, Iron Metabolism and Hydroxyurea Treatment

Ioannis Papassotiriou, PhD, Pagona Flevari, MD, Christos Poziopoulos, MD, Sofia Zaliou, PhD, Vasilis Tsaousis, PhD, Katerina Larissi, MD, Maria Dimopoulou, MD, Veroniki Komninaka, MD, Marianna Politou, MD, Evangelos Terpos, MD, Ersi Voskaridou

Blood (2019) 134 (Supplement_1): 4821.

https://doi.org/10.1182/blood-2019-121622

Published: 2019

Journal Articles

Decreased Iron Utilization Leads to Dysregulation of Iron Homeostasis in Aplastic Anemia

Aruna Barade, MTech, Sreenithi Santhakumar, MTech, Biju George, DM, Eunice Sindhuvi Edison, PhD

Blood (2018) 132 (Supplement 1): 3872.

https://doi.org/10.1182/blood-2018-99-118010

Published: 2018

Journal Articles

A Shared Signaling Network That Maintains Erythroid Homeostasis By Activating Stress Erythropoiesis Regulates Inflammation: Implications for the Anemia of Chronic Inflammation

James Fraser, BSc, Adwitia Dey, BSc, MS, Shaneice Nettleford, BSc, Siyang Hao, BSc, Luming Zhao, BSc, Pamela Hankey-Giblin, PhD, K. Sandeep Prabhu, PhD, Na Xiong, PhD, Robert Paulson, PhD

Blood (2018) 132 (Supplement 1): 629.

https://doi.org/10.1182/blood-2018-99-113448

Published: 2018

Journal Articles

Erythroferrone Inhibits the Induction of Hepcidin By BMP6

Joao Arezes, BS, MSc, PhD, Niall Foy, Kirsty McHugh, Anagha Sawant, Susan Benard, Doris Quinkert, Virginie Terraube, Alette Brinth, May Tam, Edward LaVallie, Stephen Taylor, Andrew E Armitage, Sant-Rayn Pasricha, MD PhD, Orla Cunningham, PhD, Matthew Lambert, Simon J Draper, Reema Jasuja, PhD, Alexander Drakesmith

Blood (2018) 132 (Supplement 1): 850.

https://doi.org/10.1182/blood-2018-99-111140

Published: 2018

Journal Articles

Communication of Placental Iron Trafficking Proteins with Maternal and Fetal Iron Regulators

Sreenithi Santhakumar, MTech, Rekha Athiyarath, PhD, Anne George Cherian, MD, Vinod Abraham, MD, Biju George, DM, Eunice Sindhuvi Edison, PhD

Blood (2018) 132 (Supplement 1): 3629.

https://doi.org/10.1182/blood-2018-99-116344

Published: 2018

Journal Articles

GDF15 and Erythroferrone Mark Erythropoietic Response to ACE-011 (Sotatercept) in Thalassemia

Blood (2018) 132 (Supplement 1): 3633.

https://doi.org/10.1182/blood-2018-99-111770

Published: 2018

Journal Articles

Probing Distinct Oncogene Addiction By Novel BCL-2 Inhibitors

Jing Deng, PhD, Yan Yin, MS, Tingting Mao, MS, Guoqin Zhai, MS, Dongmei Yang, MS, Douglas Fang, MD PhD, Shaomeng Wang, PhD, Yifan Zhai, MD PhD, Dajun Yang, MD PhD

Blood (2018) 132 (Supplement 1): 2616.

https://doi.org/10.1182/blood-2018-99-119816

Published: 2018

Journal Articles

Evidence for an Alternative Mechanism Suppressing Hepcidin during the Recovery from Hemorrhage-Induced Anemia

Ugo Sardo, MS, Prunelle Perrier, BS, Benjamin Billore, BS, Kevin Cormier, MS, Leon C. Kautz, PhD

Blood (2018) 132 (Supplement 1): 1047.

https://doi.org/10.1182/blood-2018-99-118647

Published: 2018

Journal Articles

Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis

Efstathios Kastritis, Ioannis Papassotiriou, Giampaolo Merlini, Paolo Milani, Evangelos Terpos, Marco Basset, Athanasios Akalestos, Francesca Russo, Erasmia Psimenou, Filia Apostolakou, Maria Roussou, Maria Gavriatopoulou, Evangelos Eleutherakis-Papaiakovou, Despina Fotiou, Dimitrios C. Ziogas, Elektra Papadopoulou, Constantinos Pamboucas, Meletios A. Dimopoulos, Giovanni Palladini

Blood (2018) 131 (14): 1568–1575.

https://doi.org/10.1182/blood-2017-12-819904

Published: 2018

Includes: Supplemental data

Journal Articles

Dyserythropoiesis Evaluated By Red Score and Hepcidin/Ferritin Levels Predicts Response to Epoetin Zeta in Lower Risk MDS

Blood (2017) 130 (Supplement 1): 1705.

https://doi.org/10.1182/blood.V130.Suppl_1.1705.1705

Published: 2017

Journal Articles

Open Label Phase I Study of Single Agent Oral RG7388 (idasanutlin) in Patients with Polycythemia Vera and Essential Thrombocythemia

John Mascarenhas, MD, Min Lu, PhDMD, Elizabeth Virtgaym, Heidi Kosiorek, MS, Marina Stal, Lonette Sandy, Alicia Orellana, MD MPH, Lijuan Xia, Marina Kremyanskaya, MD PhD, Bruce Petersen, MD, Amylou Dueck, PhD, Ronald Hoffman, MD

Blood (2017) 130 (Supplement 1): 254.

https://doi.org/10.1182/blood.V130.Suppl_1.254.254

Published: 2017

Journal Articles

Erythroferrone (ERFE) and Hepcidin Levels in Sickle Cell Disease with and without Transfusional Iron Overload

Fahim Thawer, Abdullah Kutlar, MD, Latanya Bowman, RN, Leigh Wells, MSN, Xu Hongyan, PhD, Niren Patel, MBBS, Pritam Bora, BA

Blood (2017) 130 (Supplement 1): 3518.

https://doi.org/10.1182/blood.V130.Suppl_1.3518.3518

Published: 2017

Journal Articles

Distinct Biomarkers Reflect Pathophysiological Differences of Sickle Cell Disease Sub-Phenotypes: Viscosity-Vaso-Occlusion Vs. Hemolysis-Endothelial Dysfunction

Ioannis Papassotiriou, PhD, Christos Poziopoulos, MD, Katerina Larissi, MD, Alexandra Margeli, Marianna Politou, MD, Evangelos Terpos, MD, Ersi Voskaridou

Blood (2017) 130 (Supplement 1): 3520.

https://doi.org/10.1182/blood.V130.Suppl_1.3520.3520

Published: 2017

Journal Articles

Vascular and Hemostatic Alterations Associated with Pulmonary Hypertension in β-Thalassemia Hemoglobin E Patients Receiving Regular Transfusion and Iron Chelation

Noppacharn Uaprasert, MB, BCH, Sudarat Satitthummanid, MD MSc, Benjaporn Akkawat, BSc, Pranee Sutcharitchan, MD, Ponlapat Rojnuckarin, MD PhD

Blood (2017) 130 (Supplement 1): 1029.

https://doi.org/10.1182/blood.V130.Suppl_1.1029.1029

Published: 2017

Journal Articles

Endothelial Cell-Selective Adhesion Molecule (ESAM) Plays Important Roles in the Adult-Type Hemoglobin Synthesis during Fetal Erythropoiesis

Tomoaki Ueda, Takafumi Yokota, MD PhD, Yasuhiro Shingai, Yukiko Doi, Tomohiko Ishibashi, Takao Sudo, Akira Tanimura, Michiko Ichii, MD PhD, Sachiko Ezoe, Hirohiko Shibayama, MD PhD, Kenji Oritani, MD PhD, Yuzuru Kanakura, MD PhD

Blood (2017) 130 (Supplement 1): 1157.

https://doi.org/10.1182/blood.V130.Suppl_1.1157.1157

Published: 2017

Journal Articles

CD34/EPO-R Double Positive MDS Cells Produce Erythroferrone in Response to Erythropoietin

Blood (2016) 128 (22): 2455.

https://doi.org/10.1182/blood.V128.22.2455.2455

Published: 2016

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Renal Biomarker with Potential Clinical Applications in Monoclonal Gammopathy of Renal Significance (MGRS)

Does Gene Therapy in Beta Thalassemia Normalize Novel Markers of Ineffective Erythropoiesis and Iron Homeostasis?

Serum Neutrophil Gelatinase-Associated Lipocalin Independently Predicts for Renal Response in Myeloma Patients with Severe Renal Impairment

Evaluation of in Vitro Macrophage Characterization in Gaucher Type 1 (GD1) Patients

Non Invasive Evaluation of Bone Marrow Activity in Patients with Sickle Cell Disease: Correlation with Disease Features, Genotype, Markers of Erythropoiesis, Iron Metabolism and Hydroxyurea Treatment

Decreased Iron Utilization Leads to Dysregulation of Iron Homeostasis in Aplastic Anemia

A Shared Signaling Network That Maintains Erythroid Homeostasis By Activating Stress Erythropoiesis Regulates Inflammation: Implications for the Anemia of Chronic Inflammation

Erythroferrone Inhibits the Induction of Hepcidin By BMP6

Communication of Placental Iron Trafficking Proteins with Maternal and Fetal Iron Regulators

GDF15 and Erythroferrone Mark Erythropoietic Response to ACE-011 (Sotatercept) in Thalassemia

Probing Distinct Oncogene Addiction By Novel BCL-2 Inhibitors

Evidence for an Alternative Mechanism Suppressing Hepcidin during the Recovery from Hemorrhage-Induced Anemia

Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis

Dyserythropoiesis Evaluated By Red Score and Hepcidin/Ferritin Levels Predicts Response to Epoetin Zeta in Lower Risk MDS

Open Label Phase I Study of Single Agent Oral RG7388 (idasanutlin) in Patients with Polycythemia Vera and Essential Thrombocythemia

Erythroferrone (ERFE) and Hepcidin Levels in Sickle Cell Disease with and without Transfusional Iron Overload

Distinct Biomarkers Reflect Pathophysiological Differences of Sickle Cell Disease Sub-Phenotypes: Viscosity-Vaso-Occlusion Vs. Hemolysis-Endothelial Dysfunction

Vascular and Hemostatic Alterations Associated with Pulmonary Hypertension in β-Thalassemia Hemoglobin E Patients Receiving Regular Transfusion and Iron Chelation

Endothelial Cell-Selective Adhesion Molecule (ESAM) Plays Important Roles in the Adult-Type Hemoglobin Synthesis during Fetal Erythropoiesis

CD34/EPO-R Double Positive MDS Cells Produce Erythroferrone in Response to Erythropoietin

Email alerts

ASH Publications

American Society of Hematology